A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
COVID-19 vaccination linked to lower risk for postinfection outcomes
Mar 13, 2024
A reduced risk was seen for venous thromboembolism, arterial thrombosis/thromboembolism and heart failure.
Health officials recommend spring COVID-19 booster for older adults
Feb 29, 2024
A second booster is appropriate as long as at least four months have passed since a person’s last COVID-19 shot.
CDC may recommend COVID boosters for some this spring
Feb 16, 2024
The panel is expected to focus on the safety of high-risk Americans, including people 65 and older and anyone with a weakened immune system.
COVID-19 mRNA vaccines safe during pregnancy
Feb 13, 2024
In a large study, there were lower odds of neonatal mortality associated with vaccination.
Updated COVID-19 vaccine has effectiveness of 54 percent
Feb 06, 2024
Vaccine effectiveness was 49% at 60 to 119 days after vaccination among tests exhibiting spike gene target failure.
Preexisting conditions seen in all patients with tachycardia after COVID-19 vaccine
Jan 10, 2024
Reduced heart rate variability was observed in patients with postvaccination postural orthostatic tachycardia syndrome.